CASBF Stock: CanSino Biologics Inc. Stock Price, Analysis & Insights
Get live CASBF stock price $3.10, comprehensive CanSino Biologics Inc. stock analysis, charts, news, and expert forecast. Real-time CASBF stock data and investment insights.
Loading chart data...
CanSino Biologics Inc. (CASBF) Overview
CanSino Biologics Inc. (CASBF) is a publicly traded company in the Healthcare sector , specifically within the Drug Manufacturers - Specialty & Generic industry . As of the latest trading session, CASBF trades at $3.10 with a market capitalization of 1.08B . Over the past 52 weeks, CASBF has traded between $3.00 and $6.99 , with the current price positioned at approximately 3% of this range . T...
Key Takeaways
- Operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic)
- Market cap: 1.08B
- Current price: $3.10
- 52-week range: $3.00 - $6.99
- P/E ratio: 155.00
Investment Score
A systematic tri-factor framework that integrates valuation, business quality, and market momentum into one investment signal. This helps investors triage opportunities faster, while surfacing risk regimes that may require tighter position sizing or deeper due diligence.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
CanSino Biologics Inc. is a Chinese biotechnology company dedicated to the research, development, manufacturing, and marketing of vaccines within the People's Republic of China. The company's current vaccine pipeline includes prominent candidates suc...
Company Information
- CEO
- Xuefeng Yu
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 1105
Contact Information
- Website
- https://www.cansinotech.com
- Address
- 401-420, Biomedical Park
- Country
- CN
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Growth-oriented company with premium valuation (P/E: 155.0)
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for CanSino Biologics Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for CanSino Biologics Inc.
- ⚠Investors should consider how CanSino Biologics Inc. fits within their overall portfolio allocation
- ⚠Premium valuation (P/E: 155.0) requires strong growth to justify
Market Cap
1.08B
P/E Ratio (TTM)
155.00
Beta
1.16
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare CASBF with peer companies:
- Price
- $8.77
- Market cap
- 3.89B
- Price
- $26.53
- Market cap
- 1.95B
- Price
- $1.35
- Market cap
- 3.27B
- Price
- $10.83
- Market cap
- 2.86B
- Price
- $39.56
- Market cap
- 1.96B
- Price
- $29.00
- Market cap
- 2.04B
- Price
- $15.35
- Market cap
- 3.30B
- Price
- $31.40
- Market cap
- 2.12B
- Price
- $0.19
- Market cap
- 1.69B
- Price
- $23.20
- Market cap
- 1.73B
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.